Weiss Multi-Strategy Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,995
Closed -$3.71M 702
2023
Q2
$3.71M Buy
+16,995
New +$3.79M 0.08% 353
2014
Q3
Sell
-8,740
Closed -$445K 714
2014
Q2
$443K Sell
8,740
-13,720
-61% -$680K 0.01% 539
2014
Q1
$1M Buy
22,460
+11,110
+98% +$499K 0.02% 476
2013
Q4
$534K Sell
11,350
-520
-4% -$26.3K 0.01% 606
2013
Q3
$627K Buy
11,870
+4,901
+70% +$238K 0.01% 489
2013
Q2
$315K Buy
+6,969
New +$331K 0.01% 565

Other funds holding RMD

Weiss Multi-Strategy Advisers's RMD Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of ResMed (RMD) in Q3 2023, closing a stake of 16,995 shares — an estimated $3.71M sold.

Weiss Multi-Strategy Advisers first reported a position in RMD in Q2 2013 and held it in 6 quarters. The position peaked at $3.71M in Q2 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 16,995 ResMed shares in Q3 2023, an estimated $3.71M.
  • Weiss Multi-Strategy Advisers first reported a position in ResMed in Q2 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's ResMed position peaked at $3.71M in Q2 2023.
  • 657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.